Home › Research › Mild cognitive impairment
Plasma Biomarkers and Disease Prognosis in Mild Cognitive Impairment with Lewy Bodies
Paul C. Donaghy, Jahfer Hasoon, Calum Alexander Hamilton, Joanna Ciafone, Rory Durcan, Nicola A. Barnett, Kirsty Olsen, Sarah Lawley et al.. Movement Disorders, 2025-03-29
Topic: Brain proteins, microglia and lab models
Plain-language summary
Baseline plasma NfL was associated with increased risk of dementia/death in the entire cohort. In MCI-LB, baseline plasma NfL, GFAP, and pTau181 were associated with increased risk of dementia/death and increased cognitive decline measured by the Addenbrooke's Cognitive Examination-Revised. pTau181, GFAP, and NfL are associated with more rapid disease progression in MCI-LB and, with further validation, could be useful to support prognosis and stratification for clinical practice and treatment trials. Further work, including clinicopathological studies, is needed to understand the biological correlates of these markers in MCI-LB. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 131 participants. This study found that baseline plasma neurofilament light, GFAP, and pTau181 were associated with increased risk of dementia or death and faster cognitive decline in people with mild cognitive impairment with Lewy bodies. These markers could help prognosis and stratification, but no treatment is tested.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Donaghy, P. C., Hasoon, J., Hamilton, C. A., Ciafone, J., Durcan, R., Barnett, N. A., et al. (2025). Plasma Biomarkers and Disease Prognosis in Mild Cognitive Impairment with Lewy Bodies. Movement Disorders. https://doi.org/10.1002/mds.30181
Vancouver
Donaghy PC, Hasoon J, Hamilton CA, Ciafone J, Durcan R, Barnett NA, et al. Plasma Biomarkers and Disease Prognosis in Mild Cognitive Impairment with Lewy Bodies. Movement Disorders. 2025. doi:10.1002/mds.30181. PMID: 40156325.
BibTeX
@article{donaghy2025-40156325,
author = {Donaghy, Paul C. and Hasoon, Jahfer and Hamilton, Calum Alexander and Ciafone, Joanna and Durcan, Rory and Barnett, Nicola A. and Olsen, Kirsty and Lawley, Sarah and others},
title = {{Plasma Biomarkers and Disease Prognosis in Mild Cognitive Impairment with Lewy Bodies}},
journal = {Movement Disorders},
year = {2025},
doi = {10.1002/mds.30181},
pmid = {40156325},
url = {https://doi.org/10.1002/mds.30181}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Baseline plasma NfL was associated with increased risk of dementia/death in the entire cohort.
- In MCI-LB, baseline plasma NfL, GFAP, and pTau181 were associated with increased risk of dementia/death and increased cognitive decline measured by the Addenbrooke's Cognitive Examination-Revised. pTau181, GFAP, and NfL are associated with more rapid disease progression in MCI-LB and, with further v
- Further work, including clinicopathological studies, is needed to understand the biological correlates of these markers in MCI-LB. © 2025 The Author(s).
- Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Why it matters
This study found that baseline plasma neurofilament light, GFAP, and pTau181 were associated with increased risk of dementia or death and faster cognitive decline in people with mild cognitive impairment with Lewy bodies. These markers could help prognosis and stratification, but no treatment is tested.
Study details
- Study designlongitudinal study
- Participants131
- Evidence strengthModerate
How this study scored 56/100
Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Movement Disorders) |
| Journal's citation record | 3 / 4 | Movement Disorders: journal h-index 281 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 131 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 3 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Alan J. Thomas: h-index 81 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University College London: institution h-index 2,029 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 13 institution(s) in 3 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40156325) |
| Free to read | 2 / 2 | Free to read |
| Total | 56 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Mild cognitive impairment from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.